Andelyn's Curator Platform Gets US FDA-Approved Manufacturing
Andelyn Biosciences’ Curator Platform achieves a first US FDA-approved commercial gene therapy manufacturing milestone with Ultragenyx’s Fayuvi approval.
Andelyn Biosciences | 22/09/2026 | By News Bureau
Genprex Selects Andelyn Biosciences for Scale-Up Manufacturing of Diabetes Gene Therapy
Genprex’s gene therapy candidate aims to restore insulin-producing function in diabetes by delivering Pdx1 and MafA genes to the pancreas using an AAV vector.
Andelyn Biosciences | 03/09/2026 | By Akanki
Andelyn Biosciences and ENCell Forge Global Manufacturing Alliance
Andelyn Biosciences and ENCell partner to build a cross-continental manufacturing network, enabling faster development and global delivery of advanced gene therapies.
Andelyn Biosciences | 23/04/2026 | By News Bureau | 174
Collaboration Aims to Scale AAV Manufacturing for Rare Neuromuscular Junction Diseases
NMJ disorders often cause severe muscle weakness, with many patients requiring respiratory support, wheelchairs, or tube feeding. These genetic diseases can be life-threatening, often diagnosed in childhood but sometimes appearing later in life.
Andelyn Biosciences | 24/08/2025 | By Darshana | 160
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy